ArticleRSC advances2025

Correction: LC-MS/MS characterization of pirtobrutinib impurities and product degradation: stability studies.

Modachakanahally K Pavithra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.